150 related articles for article (PubMed ID: 2698795)
1. "Mycelial vaginal test" and Candida susceptibility.
Simonetti G; Simonetti N; Villa A
Drugs Exp Clin Res; 1989; 15(10):487-90. PubMed ID: 2698795
[TBL] [Abstract][Full Text] [Related]
2. Influence of estrogen and normal flora on vaginal candidiasis in the rat.
Larsen B; Galask RP
J Reprod Med; 1984 Dec; 29(12):863-8. PubMed ID: 6394756
[TBL] [Abstract][Full Text] [Related]
3. Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence.
Trumbore DJ; Sobel JD
Obstet Gynecol; 1986 Jun; 67(6):810-2. PubMed ID: 3517722
[TBL] [Abstract][Full Text] [Related]
4. Candida albicans: the estrogen target for vaginal colonization.
Tarry W; Fisher M; Shen S; Mawhinney M
J Surg Res; 2005 Dec; 129(2):278-82. PubMed ID: 16111702
[TBL] [Abstract][Full Text] [Related]
5. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
6. Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?
Novikova N; Rodrigues A; Mårdh PA
Infect Dis Obstet Gynecol; 2002; 10(2):89-92. PubMed ID: 12530485
[TBL] [Abstract][Full Text] [Related]
7. Effect of progesterone on Candida albicans vaginal pathogenicity.
Alves CT; Silva S; Pereira L; Williams DW; Azeredo J; Henriques M
Int J Med Microbiol; 2014 Nov; 304(8):1011-7. PubMed ID: 25183575
[TBL] [Abstract][Full Text] [Related]
8. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of Candida albicans by human vaginal epithelial cells.
Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
[TBL] [Abstract][Full Text] [Related]
10. [Utilization of enzymatic activity in strains of Candida isolated from the vagina for typing and evaluation of pathogenicity].
Krzemińska-Jaśkowiak E; Pietkiewicz K; Ozdowska B
Med Dosw Mikrobiol; 1994; 46(3):225-31. PubMed ID: 7996941
[TBL] [Abstract][Full Text] [Related]
11. Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulsed-field gel electrophoresis.
Fodor E; Dósa E; Nagy A; Nagy E; Ferenczy L
Acta Microbiol Immunol Hung; 2002; 49(1):59-68. PubMed ID: 12073826
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of candidal colpitis using a semiliquid culture medium.
Räisänen S; Eskelinen S; Merilä M; Kaartinen M
Ann Chir Gynaecol; 1982; 71(6):340-3. PubMed ID: 6818889
[TBL] [Abstract][Full Text] [Related]
13. Quantification of vaginal Candida albicans infections in rodents.
Ryley JF; McGregor S
J Med Vet Mycol; 1986 Dec; 24(6):455-60. PubMed ID: 3553521
[TBL] [Abstract][Full Text] [Related]
14. [Distribution of Candida species in vaginal specimens and evaluation of CHROMagar Candida medium].
Gültekin B; Yazici V; Aydin N
Mikrobiyol Bul; 2005 Jul; 39(3):319-24. PubMed ID: 16358491
[TBL] [Abstract][Full Text] [Related]
15. Correlative relationship between adherence of Candida albicans to human vaginal epithelial cells in vitro and candidal vaginitis.
Segal E; Soroka A; Schechter A
Sabouraudia; 1984; 22(3):191-200. PubMed ID: 6379915
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
Liu XP; Fan SR; Bai FY; Li J; Liao QP
Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
[TBL] [Abstract][Full Text] [Related]
17. [The distribution of Candida species isolated from vaginal discharge].
Cengiz AT; Ataoğlu H; Cengiz L; Seyhun A; Gülmezoğlu M; Kiliç H
Mikrobiyol Bul; 1989 Oct; 23(4):275-83. PubMed ID: 2488934
[TBL] [Abstract][Full Text] [Related]
18. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis.
Pericolini E; Gabrielli E; Ballet N; Sabbatini S; Roselletti E; Cayzeele Decherf A; Pélerin F; Luciano E; Perito S; Jüsten P; Vecchiarelli A
Virulence; 2017 Jan; 8(1):74-90. PubMed ID: 27435998
[TBL] [Abstract][Full Text] [Related]
20. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
Cernicka J; Subik J
Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
